Charles M Warden insider trades: Flexion Therapeutics (FLXN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
and 1 more company
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2016 | FLXN | ↑ Buy | 714,285 | $14.00 | $10.0M | Indirect | Jun 10, 2016 (2d) |
| May 23, 2016 | PZRX | ↑ Buy | 596,477 | $5.00 | $3.0M | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↑ Buy | 3,523 | $5.00 | $18K | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 256,529 | $0.01 | $3K | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 1,515 | $0.01 | $15 | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| Jun 15, 2015 | OCUL | ↓ Sell | 320,000 | $22.00 | $7.0M | Indirect | Jun 15, 2015 (0d) |
| Jun 10, 2015 | OCUL | ↓ Sell | 427,000 | $22.00 | $9.4M | Indirect | Jun 11, 2015 (1d) |
| Jan 5, 2015 | INGN | ↓ Sell | 7,946 | $30.98 | $246K | By Lubash Moses LLC and Evan Michael Mos | Jan 6, 2015 (1d) |
| Dec 23, 2014 | INGN | ↓ Sell | 9,785 | $29.74 | $291K | Direct | Dec 29, 2014 (6d) |
| Nov 19, 2014 | INGN | ↓ Sell | 14,929 | $24.73 | $369K | By Lubash Moses LLC and Evan Michael Mos | Nov 19, 2014 (0d) |
| Nov 18, 2014 | INGN | ↓ Sell | 7,953 | $24.79 | $197K | By Robertson Family Trust | Nov 19, 2014 (1d) |
| Nov 17, 2014 | INGN | ↓ Sell | 5,343 | $24.89 | $133K | Indirect | Nov 19, 2014 (2d) |
| Nov 14, 2014 | INGN | ↓ Sell | 9,433 | $25.13 | $237K | Indirect | Nov 14, 2014 (0d) |
| Nov 10, 2014 | INGN | ↓ Sell | 5,596 | $24.48 | $137K | By Lubash Moses LLC and Evan Michael Mos | Nov 12, 2014 (2d) |
| Nov 10, 2014 | INGN | ↓ Sell | 3,041 | $24.57 | $75K | By Robertson Family Trust | Nov 12, 2014 (2d) |
| Nov 7, 2014 | INGN | ↓ Sell | 7,388 | $24.30 | $180K | Indirect | Nov 7, 2014 (0d) |
| Sep 18, 2009 | HLCS | ↑ Buy | 242,931 | $2.57 | $625K | Versant Venture Capital II, L.P. | Sep 21, 2009 (3d) |
| May 30, 2007 | HLCS | ↑ Buy | 111,111 | $9.00 | $1000K | Versant Venture Capital II, L.P. | Jun 1, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Charles M Warden's insider trades
Charles M Warden is a 10% owner of Flexion Therapeutics (FLXN). Since May 30, 2007, Charles has reported 5 open-market purchases worth $14.6M and 13 sales worth $18.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), other transactions (9 filings), conversions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FLXN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.